A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

Firms faced off at two trials in London earlier this year centred on the use of messenger RNA (mRNA) technology in ...

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

The High Court gave a mixed decision in July, ruling that one of Moderna’s two patents relating to the mRNA technology that ...

Long-standing Member of Parliament, Russell Broadbent, has written an urgent letter to the Prime Minister calling for an ...

Vaccines have to meet high effectiveness and safety standards before they are offered to the public and continue to maintain a good ongoing safety record. In Aotearoa New Zealand (NZ) Medsafe has a ...

The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.

As the Centers for Disease Control and Prevention (CDC) finds that only one-quarter of older adults have received their ...

The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and ...

Charity’s report highlights extreme global inequality, accuses mega-corporations of shaping global rules in their favor ...

There are two new treatments aimed at reducing respiratory syncytial virus (RSV) in infants. In most cases, RSV causes mild, cold-like symptoms, but for infants and the elderly, it can be much more ...